Outputs (13)

Clusterin secretion is attenuated by the proinflammatory cytokines interleukin-1β and tumor necrosis factor-α in models of cartilage degradation (2020)
Journal Article
Matta, C., Fellows, C. R., Quasnichka, H., Williams, A., Jeremiasse, B., Allaway, D., & Mobasheri, A. (2021). Clusterin secretion is attenuated by the proinflammatory cytokines interleukin-1β and tumor necrosis factor-α in models of cartilage degradation. Journal of Orthopaedic Research, 39(5), 1017-1029. https://doi.org/10.1002/jor.24814

The protein clusterin has been implicated in the molecular alterations that occur in articular cartilage during osteoarthritis (OA). Clusterin exists in two isoforms with opposing functions, and their roles in cartilage have not been explored. The se... Read More about Clusterin secretion is attenuated by the proinflammatory cytokines interleukin-1β and tumor necrosis factor-α in models of cartilage degradation.

Chondrogenic differentiation of human chondrocytes cultured in the absence of ascorbic acid (2018)
Journal Article
Asnaghi, M. A., Duhr, R., Quasnichka, H., Hollander, A. P., Kafienah, W., Martin, I., & Wendt, D. (2018). Chondrogenic differentiation of human chondrocytes cultured in the absence of ascorbic acid. Journal of Tissue Engineering and Regenerative Medicine, 12(6), 1402-1411. https://doi.org/10.1002/term.2671

Bioreactor systems will likely play a key role in establishing regulatory compliant and cost-effective production systems for manufacturing engineered tissue grafts for clinical applications. However, the automation of bioreactor systems could become... Read More about Chondrogenic differentiation of human chondrocytes cultured in the absence of ascorbic acid.

The effect of simvastatin on novel exploratory biomarkers of cartilage degradation (2018)
Journal Article
Quasnichka, H., Budd, E., Tarlton, J., Roberts, S., Jackson, C., Caterson, B., & Mobasheri, A. (2018). The effect of simvastatin on novel exploratory biomarkers of cartilage degradation. Osteoarthritis and Cartilage, 26(Supplement 1), S192. https://doi.org/10.1016/j.joca.2018.02.411

There is emerging evidence of an association between osteoarthritis (OA) and atherosclerosis, with an underlying metabolic syndrome potentially driving the progression of both diseases. Proteomic analysis of OA synovial fluid, degenerative cartilage... Read More about The effect of simvastatin on novel exploratory biomarkers of cartilage degradation.

Aggrecanase degradation of type III collagen is associated with clinical knee pain (2018)
Journal Article
Bay-Jensen, A., Kjelgaard-Petersen, C., Petersen, K., Arendt-Nielsen, L., Quasnichka, H., Mobasheri, A., …Leeming, D. (2018). Aggrecanase degradation of type III collagen is associated with clinical knee pain. Clinical Biochemistry, 58, 37-43. https://doi.org/10.1016/j.clinbiochem.2018.04.022

There is a lack of biochemical markers for non-invasive and objective assessment of symptomatic osteoarthritis (OA). Aggrecanase activity has been shown to be associated with joint deterioration and symptomatic disease through the degradation of extr... Read More about Aggrecanase degradation of type III collagen is associated with clinical knee pain.

Metabolomics and metabolic function analysis of the secretome of articular cartilage and isolated chondrocytes in response to pro-inflammatory cytokines (2018)
Journal Article
Fellows, C., Quasnichka, H., Chowdhury, N., Budd, E., Skene, D., & Mobasheri, A. (2018). Metabolomics and metabolic function analysis of the secretome of articular cartilage and isolated chondrocytes in response to pro-inflammatory cytokines. Osteoarthritis and Cartilage, 26(Supplement 1), S172. https://doi.org/10.1016/j.joca.2018.02.373

Chondrocytes rely primarily on glycolysis to meet their energy requirements, but possess the metabolic flexibility to support cell survival and matrix synthesis during periods of nutrient stress, by enhancing glycolysis with mitochondrial respiration... Read More about Metabolomics and metabolic function analysis of the secretome of articular cartilage and isolated chondrocytes in response to pro-inflammatory cytokines.

Chondrocyte secretome: A source of novel insights and exploratory biomarkers of osteoarthritis (2017)
Journal Article
Sanchez, C., Bay-Jensen, A. C., Pap, T., Dvir-Ginzberg, M., Quasnichka, H., Barrett-Jolley, R., …Henrotin, Y. (2017). Chondrocyte secretome: A source of novel insights and exploratory biomarkers of osteoarthritis. Osteoarthritis and Cartilage, 25(8), 1199-1209. https://doi.org/10.1016/j.joca.2017.02.797

The extracellular matrix (ECM) of articular cartilage is comprised of complex networks of proteins and glycoproteins, all of which are expressed by its resident cell, the chondrocyte. Cartilage is a unique tissue given its complexity and ability to r... Read More about Chondrocyte secretome: A source of novel insights and exploratory biomarkers of osteoarthritis.

Factors that influence cartilage implant integration during joint repair. (2016)
Journal Article
Al-obaid, A., Quasnichka, H., Tarlton, J., & Kafienah, W. (2016). Factors that influence cartilage implant integration during joint repair. International Journal of Experimental Pathology, 97(5), A1-A19. https://doi.org/10.1111/iep.12197

The low spontaneous healing capacity of articular cartilage, the avascular nature, and the acellularity of the interface of damaged cartilage, all these factors limit the integration between the implanted engineered cartilage and native articular car... Read More about Factors that influence cartilage implant integration during joint repair..

Lumican is a potential biomarker for osteoarthritis (2013)
Presentation / Conference
Quasnichka, H. (2013, September). Lumican is a potential biomarker for osteoarthritis. Paper presented at 11th World Congress of the International Cartilage Repair Society, Izmir

Purpose: Fragmentation of small leucine rich proteoglycans (SLRPs), including decorin, biglycan, lumican, keratocan and fibromodulin, has been shown to occur in osteoarthritic articular cartilage (Melrose et al, 2008). The aim of this project was to... Read More about Lumican is a potential biomarker for osteoarthritis.

Expression of lumican in the synovial fluid of patients with osteoarthritis (OA) (2011)
Journal Article
Quasnichka, H., Kerr, B. C., Jones, P., Morgan, A., Hughes, C., & Caterson, B. (2011). Expression of lumican in the synovial fluid of patients with osteoarthritis (OA). International Journal of Experimental Pathology, 92(6), A1-A38. https://doi.org/10.1111/j.1365-2613.2011.00780.x

Introduction Fragmentation of small leucine rich proteogly- cans (SLRPs), including decorin, biglycan, lumican, keratocan and fibromodulin, has been shown to occur in osteoarthritic articular cartilage (Melrose et al. 2008). We have previously sh... Read More about Expression of lumican in the synovial fluid of patients with osteoarthritis (OA).

Regulation of smooth muscle cell proliferation by β-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression (2006)
Journal Article
Quasnichka, H., Slater, S. C., Beeching, C. A., Boehm, M., Sala-Newby, G. B., & George, S. J. (2006). Regulation of smooth muscle cell proliferation by β-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression. Circulation Research, 99(12), 1329-1337. https://doi.org/10.1161/01.RES.0000253533.65446.33

We previously observed that stimulation of vascular smooth muscle cell (VSMC) proliferation with growth factors is associated with dismantling of cadherin junctions and nuclear translocation of β-catenin. In this study we demonstrate directly that gr... Read More about Regulation of smooth muscle cell proliferation by β-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.